NCT06150781View on ClinicalTrials.gov

Aimovig Pregnancy Exposure Registry

RecruitingOBSERVATIONAL

Enrollment

2,842

Participants

Timeline

Start Date

January 27, 2021

Primary Completion Date

October 28, 2027

Study Completion Date

October 28, 2027

Conditions

Migraine

Interventions

DRUG

erenumab-aooe

Dose and treatment duration will be advised by the HCP

Trial Locations (1)

27703

RECRUITING

IQVIA Virtual Site, Durham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY